Skip to main content
. 2021 Apr 29;9(2):125–134. doi: 10.4103/sjmms.sjmms_471_20

Table 3.

Comparison of efficacy between the gemcitabine and docetaxel groups

Therapeutic regimen (n=113) P

Gemcitabine + platinum (n=56), n (%) Docetaxel + platinum (n=57), n (%)
Treatment response
 CR 1 (1.8) 1 (1.8) 0.21
 PR 39 (69.6) 29 (50.9)
 SD 9 (16.1) 13 (22.8)
 PD 7 (12.5) 14 (24.6)
RR 40 (71.4) 30 (52.6) 0.04
DCR 49 (87.5) 43 (75.4) 0.099

CR – Complete remission; PR – Partial remission, SD – Stable disease; PD – Progressive disease; RR – Response rate; DCR – disease control rate